Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.49 |
| ▸ | ME2 | P23368 | 1/20 | 0.48 |
| ▸ | ME1 | P48163 | 1/20 | 0.48 |
| ▸ | ME3 | Q16798 | 1/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31149178 | 1.00 | CYP1A2 (0.62) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| Hydrochloric Acid SCHEMBL11313207 | 0.87 | CYP1A2 (0.66) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL770722 | 0.86 | CYP1A2 (0.70) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL3273261 | 0.85 | KDM4E (0.53) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL29779946 | 0.85 | CYP1A2 (0.68) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL88986 | 0.85 | CYP1A2 (0.68) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL5375009 | 0.83 | MEN1 (0.60) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL2941699 | 0.83 | MAPT (0.49) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL19691146 | 0.83 | TRPM4 (0.48) | CYP1A2KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL538425 | 0.81 | HPGD (0.58) | CYP1A2KDM4EMEN1ALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 726 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-113329993-A | Use of polyhydroxy aromatic compounds for treating fibrous substrates based on amino acids | 迈图高新材料有限责任公司 | 2021-08-31 | — | — | CN | claimed |
| CN-102665738-B | Prophylactic composition for influenza infection | MEIJI CO LTD | 2015-07-01 | — | — | CN | claimed |
| US-9027647-B2 | Treatment fluids containing a biodegradable chelating agent and methods for use thereof | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-05-12 | — | — | US | claimed |
| CN-103290077-A | Method for efficiently producing vitamin K2 by flavobacterium | HEFEI INST PHYSICAL SCI CAS | 2013-09-11 | — | — | CN | claimed |
| US-20130095542-A1 | ENGINEERED MICROORGANISMS AND INTEGRATED PROCESS FOR PRODUCING N-PROPANOL, PROPYLENE AND POLYPROPYLENE | BRASKEM S.A. (BR) | 2013-04-18 | — | — | US | claimed |
| CN-102008460-B | Anti-allergic agent | MEIJI DAIRIES CORP | 2012-09-19 | — | — | CN | claimed |
| EP-2464735-A1 | MICROORGANISMS AND PROCESS FOR PRODUCING N-PROPANOL | Braskem S.A. (BR) | 2012-06-20 | — | — | EP | claimed |
| CN-102166018-A | Method of stabilizing 1,4-dihydroxy-2-naphthoic acid | MEIJI DAIRIES CORP | 2011-08-31 | — | — | CN | claimed |
| US-7997342-B2 | Subterranean treatment fluids comprising viscoelastic surfactant gels | HALLIBURTON ENERGY SERVICES, INC. (US) | 2011-08-16 | — | — | US | claimed |
| CN-1860236-A | Process for producing 1,4-dihydoxy-2-naphthoic acid | MEIJI DAIRIES CORP (JP) | 2006-11-08 | — | — | CN | claimed |
| CN-1820741-A | Process for producing 1,4-dihydroxy-2-naphthoic acid | MEIJI DAIRIES CORP (JP) | 2006-08-23 | — | — | CN | claimed |
| EP-1422256-B1 | THERMOTROPIC LIQUID-CRYSTAL POLYMER | UENO SEIYAKU OYO KENKYUJO KK (JP) | 2006-08-02 | — | — | EP | claimed |
| CN-1764627-A | Method for stabilizing 1, 4-dihydroxy-2-naphthoic acid | MEIJI DAIRIES CORP (JP) | 2006-04-26 | — | — | CN | claimed |
| CN-1539019-A | Method for producing 1, 4-dihydroxy-2-naphthoic acid | ͬ�Ϳ�ҵ��ʽ���� | 2004-10-20 | — | — | CN | claimed |
| CN-1501964-A | The use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | �������⻯ѧƷ�ع�����˾ | 2004-06-02 | — | — | CN | claimed |
| EP-1370614-A1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | Ciba SC Holding AG (CH) | 2003-12-17 | — | — | EP | claimed |
| US-6626990-B2 | Using aromatic- or heteraromatic-compounds having at least one hydroxyl or keto group bonded to the ring, with the oxidation of corresponding dihydroquinacridone salts | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-09-30 | — | — | US | claimed |
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2002-10-31 | — | — | US | claimed |
| WO-2002077104-A1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-10-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | QDPR, POLR2H, POLR2E | CYP1A2 192/4885KDM4E 3124/4885MEN1 4591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.